Executive Board

orange__line

At MedSIR, we scout for the best strategic ideas and set the wheels in motion to development them into game-changing clinical trials in oncology.

  • ANNA GIBERNAU

    ANNA GIBERNAU

    Executive Director

    With a PhD in Pharmacy (Barcelona University), Anna initiated her career on clinical research after her Master of Science in Biopharmacy at King’s College (University of London, UK) in 1992. Additional degrees include the Executive Educational Program at Wharton Business School (University of Pennsylvania, USA), Finance for Directors at ESADE Business School (Barcelona), Six Sigma Green Belt Award within the Corporate Quality Improvement department of the United Health Group (Salt Lake City, USA) and PMP® from Project Management Institute® (Pennsylvania, USA).

    Anna has proven expertise to promote and execute clinical trials with risk-based approach, 6σ and PMI methodology, to cut down investment costs while maintaining quality across all project life cycle. As director has driven more than 42 clinical trials in multiple indications and lead Functional Services Provision, from Drug Early Development to Commercialization. Since 1988, she has assumed multiple roles at Pharma Industry (Laboratorios Boiron, Parke Davis, Laboratorios Cusí, Bieffe Medital) and Clinical Research Organizations (Ingenix, Inventiv Health), from Technical Director, Quality Assurance, Clinical Research Operations and Innovative scientific medical knowledge enterprises, such as MedSIR.

    Over the last 25 years she has managed clinical trials for more than 40 pharmaceutical companies worldwide and clinical research teams in Europe, South America and Asia Pacific region for drug development in oncology, neuroscience, cardiovascular, vaccines, metabolic and infectious diseases among other therapeutic areas from phase 0 to IV.

    Since 2012 Anna collaborates as Scientific Director of the Master in Clinical Research and Medical Affairs organized by CESIF.

  • MARIA CAMPOS

    MARIA CAMPOS

    Strategic Director

    María Campos earned her undergraduate degree in Pharmacy at the University of Barcelona followed by a Degree in Quality Assurance from the American Society of Quality Control and since then began her career of now more than 20 years in the field Clinical Research.

    Maria has spent the bulk of the last two decades in the field of Oncology in both US and European Pharmaceutical Companies, with the majority of her time spent in solid tumors (lung and breast cancer) and in liquid tumors such as Non-Hodgkin’s disease and Myeloma.

    Over these years Maria developed a strong interest for the development of pharmacological treatments with a special focus on the optimization and innovation of traditional drug developmental processes in order to help increase efficiency and success rates of new molecules in the “fight against cancer”. In 2012, with this goal and dream in mind, Maria helped found, together with experts in Oncology, the company called Medica Scientia Innovation Research (MedSIR) and currently holds the position of Scientific Director.

    Maria is very well-travelled and speaks Catalan, Spanish and English fluently and has working knowledge of French.

  • FRANÇOIS RIVA

    FRANÇOIS RIVA

    Business Development Director

    Following an undergraduate degree in 1998 in Molecular Biology at the University of Geneva, Switzerland, François completed a Masters degree in Biochemistry as an Erasmus student at the University of Barcelona. This lead to 3 years of basic research in neuroscience at the Jules Gonin Institute of Ophtahlamology in Lausanne Switzerland.

    In 2005, François began his career in the pharmaceutical industry as a Clinical Research Assistant in the Division of Oncology at Pierre Fabre Ibérica, working in various phase I, II, and III trials in Lung, Breast, and Bladder Cancer. This lead to a position as Regional Sales Representative for Navelbine oral and IV in Breast and Lung Cancer while completing a Masters in Pharmaceutical Marketing at the Universidad de Pompeu Fabra in Barcelona, Spain. In 2008, he moved to Roche Farma as a Sales Representative for Xeloda, Avastin, Tarceva, and Herceptin in Digestive Tumors. Following this experience, François moved to Eisai Farmaceútica as a Key Account Manager to help in the Spanish launch of Halaven in Metastatic Breast Cancer. A jump to the Medical Department in Eisai allowed François to gain valuable experience in Medical Affairs and drug development for Halaven, Lenvima in Differentiated Thyroid Cancer, and Targretin for Cutaneous T-cell Lymphoma.

    François speaks English, Spanish, and French fluently and has acquired a good knowledge of Catalan. In his free time, he enjoys various sports such as Triathlon, Tennis, and Crossfit Training.

  • ALICIA GARCÍA

    ALICIA GARCÍA

    Operations Director

    Alicia has both academic and drug development experience. On the academic side, she obtained her PhD degree in neuropharmacology and afterwards continued her post-doctoral career in pre-clinical research at the Cardiology Unit at Vall d’Hebron and Neurobiology department at the University of Barcelona.

    In drug development, Alicia started her career in clinical research at Bayer. From there she moved to positions of increasing responsibilities in different biopharma companies (Almirall, Jassen Pharmaceutica, Merck Serono and Novartis) where she was involved in the management of key clinical trials in the development of drugs such as aclidinium (COPD), bortezomib (multiple myeloma) or in the global team responsible for the development of safinamide (Parkinson’s disease). Main therapeutic areas of expertise include Oncology, Neurology and Respiratory as well as Vaccines and Fertility.

    Alicia has broad experience encompassing the entire spectrum of drug development from the early clinical to the latest phases including launch and phase IV clinical studies, with robust knowledge and overall vision of the multiple aspects involved in clinical research. She has proven ability to lead large, multinational and cross-functional teams.

    She enjoys working in an international, diverse and dynamic environment and is passionate to take on new challenges and keep learning.

MedSIR is always looking to add talented individuals to its team in a number of roles. If you are interested in getting us to know you better, please visit our Careers page to submit your CV to us.

Careers 01
Careers 02
Careers 03